Correlation Between Neoleukin Therapeutics and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Neoleukin Therapeutics and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neoleukin Therapeutics and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neoleukin Therapeutics and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Neoleukin Therapeutics and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neoleukin Therapeutics with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neoleukin Therapeutics and Apellis Pharmaceuticals.
Diversification Opportunities for Neoleukin Therapeutics and Apellis Pharmaceuticals
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Neoleukin and Apellis is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Neoleukin Therapeutics and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Neoleukin Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neoleukin Therapeutics are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Neoleukin Therapeutics i.e., Neoleukin Therapeutics and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Neoleukin Therapeutics and Apellis Pharmaceuticals
Given the investment horizon of 90 days Neoleukin Therapeutics is expected to generate 1.12 times more return on investment than Apellis Pharmaceuticals. However, Neoleukin Therapeutics is 1.12 times more volatile than Apellis Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 55.00 in Neoleukin Therapeutics on August 31, 2024 and sell it today you would earn a total of 14.00 from holding Neoleukin Therapeutics or generate 25.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 28.51% |
| Values | Daily Returns |
Neoleukin Therapeutics vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Apellis Pharmaceuticals |
Neoleukin Therapeutics and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neoleukin Therapeutics and Apellis Pharmaceuticals
The main advantage of trading using opposite Neoleukin Therapeutics and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neoleukin Therapeutics position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
| Apellis Pharmaceuticals vs. Cue Biopharma | Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. Inhibrx | Apellis Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Correlations Find global opportunities by holding instruments from different markets |